BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28074330)

  • 1. Comparison of Core Needle Biopsy and Excision Specimens for the Accurate Evaluation of Breast Cancer Molecular Markers: a Report of 1003 Cases.
    Chen J; Wang Z; Lv Q; Du Z; Tan Q; Zhang D; Xiong B; Zeng H; Gou J
    Pathol Oncol Res; 2017 Oct; 23(4):769-775. PubMed ID: 28074330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers.
    Shanmugalingam A; Hitos K; Hegde S; Al-Mashat A; Pathmanathan N; Edirimmane S; Hughes TM; Ngui NK
    Breast Cancer Res Treat; 2022 May; 193(1):151-159. PubMed ID: 35229238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients.
    Chen X; Zhu S; Fei X; Garfield DH; Wu J; Huang O; Li Y; Zhu L; He J; Chen W; Jin X; Shen K
    BMC Cancer; 2015 Oct; 15():822. PubMed ID: 26514283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-testing of predictive biomarkers on surgical breast cancer specimens is clinically relevant.
    Robertson S; Rönnlund C; de Boniface J; Hartman J
    Breast Cancer Res Treat; 2019 Apr; 174(3):795-805. PubMed ID: 30659433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the concordance rates between core needle biopsy and surgical excision in patients with breast cancer.
    Ricci MD; Calvano Filho CM; Oliveira Filho HR; Filassi JR; Pinotti JA; Baracat EC
    Rev Assoc Med Bras (1992); 2012; 58(5):532-6. PubMed ID: 23090222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
    Chen X; Yuan Y; Gu Z; Shen K
    Breast Cancer Res Treat; 2012 Aug; 134(3):957-67. PubMed ID: 22370627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
    Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
    Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single centre experience in Turkey for comparison between core needle biopsy and surgical specimen evaluation results for HER2, SISH, estrogen receptors and progesterone receptors in breast cancer patients.
    Karaman H; Senel F; Tasdemir A; Özer I; Dogan M
    J Cancer Res Ther; 2022; 18(6):1789-1795. PubMed ID: 36412445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience.
    Slostad JA; Yun NK; Schad AE; Warrior S; Fogg LF; Rao R
    Cancer Med; 2022 Dec; 11(24):4954-4965. PubMed ID: 35733293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens?
    Greer LT; Rosman M; Mylander WC; Hooke J; Kovatich A; Sawyer K; Buras RR; Shriver CD; Tafra L
    J Am Coll Surg; 2013 Feb; 216(2):239-51. PubMed ID: 23141136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
    Janeva S; Parris TZ; Nasic S; De Lara S; Larsson K; Audisio RA; Olofsson Bagge R; Kovács A
    BMC Cancer; 2021 Apr; 21(1):439. PubMed ID: 33879115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.
    Asogan AB; Hong GS; Arni Prabhakaran SK
    Singapore Med J; 2017 Mar; 58(3):145-149. PubMed ID: 27029805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer.
    Kombak FE; Şahin H; Mollamemişoğlu H; Önem İ; Kaya H; Buğdaycı O; Arıbal E
    Turk J Med Sci; 2017 Dec; 47(6):1791-1796. PubMed ID: 29306240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens.
    Tsuda H; Kurosumi M; Umemura S; Yamamoto S; Kobayashi T; Osamura RY
    BMC Cancer; 2010 Oct; 10():534. PubMed ID: 20925963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu.
    Halilovic A; Bulte J; Jacobs Y; Braam H; van Cleef P; Schlooz-Vries M; Werner A; Boelens O; Nagtegaal I; de Wilt H; Bult P
    J Clin Pathol; 2017 Sep; 70(9):781-786. PubMed ID: 28325747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core needle biopsy as an alternative to whole section in IHC4 score assessment for breast cancer prognostication.
    Liu M; Tang SX; Tsang JYS; Shi YJ; Ni YB; Law BKB; Tse GMK
    J Clin Pathol; 2018 Dec; 71(12):1084-1089. PubMed ID: 30228212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of prognostic factors in breast carcinoma determined by core needle biopsy.
    Usami S; Moriya T; Amari M; Suzuki A; Ishida T; Sasano H; Ohuchi N
    Jpn J Clin Oncol; 2007 Apr; 37(4):250-5. PubMed ID: 17485439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry.
    You K; Park S; Ryu JM; Kim I; Lee SK; Yu J; Kim SW; Nam SJ; Lee JE
    J Breast Cancer; 2017 Sep; 20(3):297-303. PubMed ID: 28970856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.
    Nakamura R; Yamamoto N; Shiina N; Miyaki T; Ikebe D; Itami M; Shida T; Miyazaki M
    Breast; 2016 Apr; 26():141-7. PubMed ID: 26732051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The appropriate number of preoperative core needle biopsy specimens for analysis in breast cancer.
    Sun T; Zhang H; Gao W; Yang Q
    Medicine (Baltimore); 2021 Apr; 100(14):e25400. PubMed ID: 33832135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.